IP Library Granted Patent US 9,999,635
Granted Patent B2
US 9,999,635 · App. 14/670,641 · Granted Jun 19, 2018

Methods and compositions for treating inflammatory disorders

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,999,635
App. No.
14/670,641
Granted
Jun 19, 2018
Kind
B2
Abstract

The present invention provides methods for treating conditions that involve infection and/or inflammation, including acute and chronic inflammation, as well as delayed-type and immediate-type hypersensitivity. The invention in various embodiments provides methods for treating microbial infection and the associated inflammatory response, as well methods for treating inflammatory conditions that spawn or are susceptible to secondary microbial infection. Further, the invention provides methods for treating inflammation, such as chronic inflammation, without any associated microbial infection.

Claims (11)

1. A method for treating inflammation associated with a hypersensitivity condition characterized by type II or type III hypersensitivity in a subject in need thereof, the method comprising: administering a hypochlorous acid formulation to an affected area comprising the eyes or skin of the subject, wherein the hypochlorous acid formulation has from 250 to 1000 ppm of available free chlorine and is at least 80% hypochlorous acid relative to the total concentration of hypochlorous acid, hypochlorite, and molecular chlorine, and wherein the method reduces inflammation of the affected area, wherein the inflammation is not associated with microbial infection.

2. The method of claim 1 , wherein the affected region is skin.

3. The method of claim 1 , wherein the hypochlorous acid formulation is hypotonic with tears.

4. The method of claim 1 , wherein the hypochlorous acid formulation is delivered as an eye drop or eye wash.

5. The method of claim 1 , wherein the hypochlorous acid formulation is administered to the affected region from 1 to 10 times per day.

6. The method of claim 1 , wherein the hypochlorous acid formulation is administered to the affected region from 1 to 4 times per day.

7. The method of claim 1 , wherein the hypochlorous acid formulation is administered in combination with one or more anti-inflammatory agents, antibiotic, antiviral agents, anti-fungus agents, anti-parasitic agents, antihistamine, anti-oxidant and moisturizer.

8. The method of claim 1 , wherein the hypochlorous acid formulation contains one or more of the following: viscosity building agent, surfactant, and buffering agent.

9. A method for treating inflammation associated with a hypersensitivity condition characterized by type II or type III hypersensitivity in a subject in need thereof, the method comprising: administering a hypochlorous acid formulation to an affected area comprising the eyes of the subject, wherein the hypochlorous acid formulation has from 250 to 600 ppm of available free chlorine and is at least 80% hypochlorous acid relative to the total concentration of hypochlorous acid, hypochlorite, and molecular chlorine, and wherein the method reduces inflammation of the affected area, wherein the inflammation is not associated with microbial infection.

10. The method of claim 9 , wherein the hypochlorous acid formulation is administered to the affected region from 1 to 10 times per day.

11. The method of claim 9 , wherein the hypochlorous acid formulation is administered to the affected region from 1 to 4 times per day.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 7, 2019
From: REALM THERAPEUTICS, INC.
To: URGO US, INC.
Reel/Frame 049405/0191 →
CHANGE OF NAME Recorded Jan 5, 2017
From: PURICORE, INC.
To: REALM THERAPEUTICS, INC.
Reel/Frame 041268/0225 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 3, 2016
From: SAMPSON, CLAIRE; SAMPSON, MARK; SCHOCKEMOEHL, CARY; PANICHEVA, SVETLANA
To: PURICORE, INC.
Reel/Frame 037879/0853 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 16, 2015
From: SAMPSON, CLAIRE; SAMPSON, MARK; PANICHEVA, SVETLANA; SCHOCKEMOEHL, CARY
To: PURICORE, INC.
Reel/Frame 037305/0638 →